Rivero-Ferrer, E. ., Olesen, M. ., Plana, E. ., Aguado, J. ., Saigi-Morgui, N. ., Rubino, A. ., … Rebordosa, C. . (2022). Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clin Drug Investig. http://doi.org/10.1007/s40261-022-01120-2
N. Kristiansen
First name
N.
Middle name
S.
Last name
Kristiansen
Margulis, A. V., Linder, M. ., Arana, A. ., Pottegard, A. ., Berglind, I. A., Bui, C. L., … Hallas, J. . (2018). Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom. PLoS One. http://doi.org/10.1371/journal.pone.0204456
Phiri, K. ., Hallas, J. ., Linder, M. ., Margulis, A. ., Suehs, B. ., Arana, A. ., … Seeger, J. . (2021). A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Curr Med Res Opin. http://doi.org/10.1080/03007995.2021.1891035
Hoffman, V. ., Hallas, J. ., Linder, M. ., Margulis, A. V., Suehs, B. T., Arana, A. ., … Seeger, J. D. (2021). Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-021-01095-7